OTHER × Observational × Carcinoma, Hepatocellular × Clear all ELEPHAS-04
Recruiting
324 enrolled
SEEK
Completed
38 enrolled
HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion
Not yet recruiting
150 enrolled
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Recruiting
500 enrolled
Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma
Recruiting
15 enrolled
Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
Recruiting
200 enrolled
Evaluation of a Machine Learning-Based Prediction Strategy for Extrahepatic Metastasis in Hepatocellular Carcinoma
Active not recruiting
800 enrolled
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
Enrolling by invitation
1,300 enrolled
Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy
Recruiting
90 enrolled
Exploring the Application of 3D Bioprinting for Personalized Treatment in Primary Liver Cancer With Tumor Microenvironment
Active not recruiting
60 enrolled
ISTAR-01
Recruiting
138 enrolled
Bio-Delta
Recruiting
20 enrolled
Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation
Completed
484 enrolled
BLOOD-TACE-M
Not yet recruiting
60 enrolled
SWITCH
Not yet recruiting
100 enrolled
Utility of MicroRNAs for Diagnosing Hepatocellular Carcinoma in Hepatitis C Patients
Completed
84 enrolled
Evaluation of Resection Techniques for Pancreatic Tumors
Recruiting
431 enrolled
RESPECT
Active not recruiting
250 enrolled
LiverINSPECT
Active not recruiting
20 enrolled
NISTIPS
Recruiting
350 enrolled
BLOOD-TACE-P
Recruiting
15 enrolled
GENDER-HCC-MET
Completed
19,019 enrolled
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
Recruiting
730 enrolled
HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)
Completed
244 enrolled
Using Machine Learning to Identify Responders to TACE or HAIC for uHCC
Completed
3,000 enrolled
RASEREM
Recruiting
150 enrolled
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Recruiting
1,200 enrolled
A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma
Not yet recruiting
250 enrolled
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma
Recruiting
2,000 enrolled
VIGILANT
Active not recruiting
652 enrolled
CoVaCheck
Not yet recruiting
200 enrolled
Liver and Biliary Tumor Tissue Registry
Terminated
1,000 enrolled
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Recruiting
84 enrolled
Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC
Completed
17 enrolled
An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer
Recruiting
80 enrolled
DETECT
Recruiting
600 enrolled
IMMUNOCELL
Terminated
4 enrolled
Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy
Enrolling by invitation
729 enrolled
EVOLVE
Completed
41 enrolled
IMMUNOGLYPIC
Recruiting
240 enrolled
Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC
Recruiting
50 enrolled
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
Completed
131 enrolled 8 charts
KURE-YTT-HCC
Active not recruiting
200 enrolled
CENTINEL
Recruiting
600 enrolled
CEUS_LR_TRA
Not yet recruiting
200 enrolled
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
Active not recruiting
51 enrolled
BORG
Completed
48 enrolled
Deep Learning-Based Multidimensional Body Composition Mapping for Outcome Prediction in HCC Patients Undergoing TACE
Recruiting
300 enrolled
Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC
Completed
1,043 enrolled
One&Done
Enrolling by invitation
30 enrolled